<DOC>
	<DOCNO>NCT00869960</DOCNO>
	<brief_summary>Data suggest woman take drug treat human immunodeficiency virus ( HIV ) high amount drug body compare men take dose anti-HIV drug . The reason high drug exposure determine . The primary purpose study examine whether pharmacokinetics ( factor determine amount drug body ) anti-HIV drug change different phase menstrual cycle woman ultimately result high amount drug body compare men . In word , plan examine whether change sex hormone throughout menstrual cycle affect amount anti-HIV drug woman . The antiretroviral drug atazanavir , ritonavir , tenofovir emtricitabine study . This study conduct healthy woman since HIV may change pharmacokinetics anti-HIV drug .</brief_summary>
	<brief_title>Impact Menstrual Cycle Antiretroviral Pharmacokinetics Healthy Women</brief_title>
	<detailed_description />
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Atazanavir Sulfate</mesh_term>
	<mesh_term>Emtricitabine</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>Healthy , HIV negative , nonsmoking female 21 40 year age . Subjects must within 20 % ideal body weight regular menstrual cycle , define least 10 cycle per year occur approximately every 28 Â± 4 day cycle length vary 7 day . Subjects must willing able provide write informed consent . Subjects breast feeding , pregnant take hormonal contraception within 3 month prior study enrollment . However , must agree use effective nonhormonal method contraception study . Subjects receive prescription overthecounter product may interact study medication exclude study . Subjects Grade 3 high laboratory liver , renal hematology abnormality specify accordance DAIDS Table Grading Severity Adult Pediatric Adverse Events ( DAIDS AE Grading Table ) Version 1.0 , Dec 2004 , exclude .</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Healthy Volunteers</keyword>
</DOC>